Cargando…

Pharmacodynamics, toxicology and toxicokinetics of ropivacaine oil delivery depot

BACKGROUND: Ropivacaine oil delivery depot (RODD) can be used to treat postoperative incision pain. The aim was to study pharmacodynamics, toxicity and toxicokinetics of RODD. METHODS: The base research of RODD were conducted. Thirty rabbits were randomly divided into saline, solvent, ropivacaine aq...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Wu-dang, Hui, Min-quan, Gu, Jing-liang, Liu, Li, Wu, Man-li, Yang, Yi, Cao, Yong-xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022296/
https://www.ncbi.nlm.nih.gov/pubmed/35448955
http://dx.doi.org/10.1186/s12871-022-01653-1
_version_ 1784690050570649600
author Lu, Wu-dang
Hui, Min-quan
Gu, Jing-liang
Liu, Li
Wu, Man-li
Yang, Yi
Cao, Yong-xiao
author_facet Lu, Wu-dang
Hui, Min-quan
Gu, Jing-liang
Liu, Li
Wu, Man-li
Yang, Yi
Cao, Yong-xiao
author_sort Lu, Wu-dang
collection PubMed
description BACKGROUND: Ropivacaine oil delivery depot (RODD) can be used to treat postoperative incision pain. The aim was to study pharmacodynamics, toxicity and toxicokinetics of RODD. METHODS: The base research of RODD were conducted. Thirty rabbits were randomly divided into saline, solvent, ropivacaine aqueous injection (RAI) 0.9 mg, RODD 0.9 mg and RODD 3 mg groups. The sciatic nerve of rabbits were isolated, dripped with RODD and the effect of nerve block were observed. In toxicity study, the rats were divided into saline, solvent and RODD 75, 150 and 300 mg/kg groups, 30 rats per group. In toxicokinetics, rats were divided into RODD 75, 150 and 300 mg/kg groups, 18 rats per group. The rats were subcutaneously injected drugs. RESULTS: The analgesic duration of RODD 3 mg and RAI 0.9 mg blocking ischiadic nerve lasted about 20 h and 2 h, respectively, and their blocking intensity was similar. The rats in RODD 75 mg/kg did not show any toxicity. Compared with saline group, in RODD 150 mg/kg group neutrophils and mononuclear cells increased, lymphocytes decreased and albumin decreased(P < 0.05), and pathological examination showed some abnormals. In RODD 300 mg/kg group, 10 rats died and showed some abnormalities in central nerve system, hematologic indexes, part of biochemical indexes, and the weights of spleen, liver, and thymus. However, these abnormal was largely recovered on 14 days after the dosing. The results of toxicokinetics of RODD 75 mg/kg group showed that the C(max) was 1.24 ± 0.59 µg/mL and the AUC((0-24 h)) was 11.65 ± 1.58 h·µg/mL. CONCLUSIONS: Subcutaneous injection RODD releases ropivacaine slowly, and shows a stable and longer analgesic effect with a large safety range.
format Online
Article
Text
id pubmed-9022296
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90222962022-04-22 Pharmacodynamics, toxicology and toxicokinetics of ropivacaine oil delivery depot Lu, Wu-dang Hui, Min-quan Gu, Jing-liang Liu, Li Wu, Man-li Yang, Yi Cao, Yong-xiao BMC Anesthesiol Research Article BACKGROUND: Ropivacaine oil delivery depot (RODD) can be used to treat postoperative incision pain. The aim was to study pharmacodynamics, toxicity and toxicokinetics of RODD. METHODS: The base research of RODD were conducted. Thirty rabbits were randomly divided into saline, solvent, ropivacaine aqueous injection (RAI) 0.9 mg, RODD 0.9 mg and RODD 3 mg groups. The sciatic nerve of rabbits were isolated, dripped with RODD and the effect of nerve block were observed. In toxicity study, the rats were divided into saline, solvent and RODD 75, 150 and 300 mg/kg groups, 30 rats per group. In toxicokinetics, rats were divided into RODD 75, 150 and 300 mg/kg groups, 18 rats per group. The rats were subcutaneously injected drugs. RESULTS: The analgesic duration of RODD 3 mg and RAI 0.9 mg blocking ischiadic nerve lasted about 20 h and 2 h, respectively, and their blocking intensity was similar. The rats in RODD 75 mg/kg did not show any toxicity. Compared with saline group, in RODD 150 mg/kg group neutrophils and mononuclear cells increased, lymphocytes decreased and albumin decreased(P < 0.05), and pathological examination showed some abnormals. In RODD 300 mg/kg group, 10 rats died and showed some abnormalities in central nerve system, hematologic indexes, part of biochemical indexes, and the weights of spleen, liver, and thymus. However, these abnormal was largely recovered on 14 days after the dosing. The results of toxicokinetics of RODD 75 mg/kg group showed that the C(max) was 1.24 ± 0.59 µg/mL and the AUC((0-24 h)) was 11.65 ± 1.58 h·µg/mL. CONCLUSIONS: Subcutaneous injection RODD releases ropivacaine slowly, and shows a stable and longer analgesic effect with a large safety range. BioMed Central 2022-04-21 /pmc/articles/PMC9022296/ /pubmed/35448955 http://dx.doi.org/10.1186/s12871-022-01653-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Lu, Wu-dang
Hui, Min-quan
Gu, Jing-liang
Liu, Li
Wu, Man-li
Yang, Yi
Cao, Yong-xiao
Pharmacodynamics, toxicology and toxicokinetics of ropivacaine oil delivery depot
title Pharmacodynamics, toxicology and toxicokinetics of ropivacaine oil delivery depot
title_full Pharmacodynamics, toxicology and toxicokinetics of ropivacaine oil delivery depot
title_fullStr Pharmacodynamics, toxicology and toxicokinetics of ropivacaine oil delivery depot
title_full_unstemmed Pharmacodynamics, toxicology and toxicokinetics of ropivacaine oil delivery depot
title_short Pharmacodynamics, toxicology and toxicokinetics of ropivacaine oil delivery depot
title_sort pharmacodynamics, toxicology and toxicokinetics of ropivacaine oil delivery depot
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022296/
https://www.ncbi.nlm.nih.gov/pubmed/35448955
http://dx.doi.org/10.1186/s12871-022-01653-1
work_keys_str_mv AT luwudang pharmacodynamicstoxicologyandtoxicokineticsofropivacaineoildeliverydepot
AT huiminquan pharmacodynamicstoxicologyandtoxicokineticsofropivacaineoildeliverydepot
AT gujingliang pharmacodynamicstoxicologyandtoxicokineticsofropivacaineoildeliverydepot
AT liuli pharmacodynamicstoxicologyandtoxicokineticsofropivacaineoildeliverydepot
AT wumanli pharmacodynamicstoxicologyandtoxicokineticsofropivacaineoildeliverydepot
AT yangyi pharmacodynamicstoxicologyandtoxicokineticsofropivacaineoildeliverydepot
AT caoyongxiao pharmacodynamicstoxicologyandtoxicokineticsofropivacaineoildeliverydepot